Clinical Trial: Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
Brief Summary: The purpose of this study is to determine whether pre-existing cardiac fibrosis is a predictor of cancer treatment-related cardiotoxicity.
Detailed Summary:
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Current Primary Outcome: Cardiotoxicity assessed clinically or by cardiac MRI [ Time Frame: 24 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Minnesota - Clinical and Translational Science Institute
Dates:
Date Received: May 12, 2016
Date Started: August 2016
Date Completion: March 2021
Last Updated: August 15, 2016
Last Verified: August 2016